Korro Bio, Inc. (KRRO)

Korro Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	142.35	169.71	36.94	81.33	222.16	200.26
Short-Term Investments	0	0	18.92	51.07	0	17.2
Cash & Cash Equivalents	142.35	169.71	55.85	132.41	222.16	217.46
Cash Growth	108.27%	203.87%	-57.82%	-40.40%	2.16%	415.43%
Other Current Assets	3.31	3.02	1.23	2.34	2.9	3.9
Total Current Assets	145.66	172.73	57.08	134.75	225.06	221.36
Property, Plant & Equipment	46.46	42.82	11.89	36.87	37.84	1.76
Long-Term Investments	3.41	3.41	4.54	11.72	0	0
Other Long-Term Assets	2.47	2.71	0.23	2.02	1.82	0.1
Total Long-Term Assets	52.33	48.94	16.66	50.61	39.66	1.86
Total Assets	197.99	221.66	73.74	185.36	264.72	223.22
Accounts Payable	4.66	7.28	2.61	2.75	5.51	1.22
Deferred Revenue	0	0	0	0	14.07	51.05
Current Debt	1.24	1.99	2.92	2.58	0.4	0
Other Current Liabilities	5.16	10.21	3.18	6.1	6.66	0.51
Total Current Liabilities	11.05	19.48	8.7	11.43	26.63	52.78
Long-Term Debt	34.68	31.22	0.21	43.02	45.6	0
Other Long-Term Liabilities	0.89	1.05	0	0.09	0	3.08
Total Long-Term Liabilities	35.57	32.27	0.21	43.11	45.6	3.08
Total Liabilities	46.63	51.75	8.91	54.53	72.23	55.86
Total Debt	35.92	33.21	3.13	45.6	45.99	0
Debt Growth	-10.14%	960.93%	-93.14%	-0.86%	-	-
Retained Earnings	-202.56	-183.01	-101.83	-180.09	-95.4	-68.89
Comprehensive Income	0	0	-0.01	-0.06	0.03	0.05
Shareholders' Equity	151.36	169.91	-99.03	130.82	192.49	167.36
Net Cash / Debt	106.43	136.51	52.72	86.81	176.17	217.46
Net Cash / Debt Growth	275.04%	158.92%	-39.27%	-50.72%	-18.99%	415.43%
Net Cash Per Share	13.27	89.26	206.61	126.35	273.10	1257.08
Working Capital	134.6	153.25	48.38	123.32	198.43	168.58
Book Value Per Share	18.87	111.10	-388.09	190.42	298.41	967.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).